Antares Pharma, Inc. (NASDAQ:ATRS) has its shares plummet by -18.18% or $0.72 from its all-time high of $3.96, with ATRS attaining that price back on March 04, 2019. The drop in the price of the shares saw it stand at $3.24 per share. ATRS has been trading at a low of $2.53 over the past one year but it surged by 28.06% or $0.71 to reach the $3.24 mark. Following the massive rise in stock price, ATRS received more attention from investors and analysts. On Wednesday, the stock plunged by 2.53%, which caused investors and analysts to excite about it. Following the plunge in price, the ATRS beta stands at 0.88, implying that its volatility level has gone down by 0.12 back of the general market. A look at the stock’s 200-day moving average shows that it is 3.84% above while its 50-day moving average shows that it is currently 3.81% above. Compared to 3.87% average daily volatility of past month, the stock’s average volatility for this week has decreased by -0.46 as the volatility level currently stands at 3.41%.
Over the past seven days, the stock has witnessed a price dip by -1.52%. This massive drop in stock price has caught the attention of both investors and market traders. The stock has performed excellently over the past 52 weeks, rising by 1.25% during that time frame and is now up by 19.12% since this point this year. ATRS has surged by 9.09% over the past 30 days, with its equity price gaining% of its value over the past ninety days. These figures add up to see the stock record a growth of 2.86% over the past six months.
The stock’s technical analysis reveals that its 14-day Relative Strength Index (RSI) is currently in a neutral position as it was able to attain 53.73 points. Over the past three months, the trading volume has jumped massively, by roughly ????118.45%???, with the trading volume now standing at 1525859 shares. The increase of 445859 shares in trading volume shows that traders and investors have shown more interest in the stock over the past few weeks. During that trading session, the average trading volume of ATRS was 1080000 shares, which is more than 1.41 times higher than its usual trading volume.
Analysts have set a 1-year price target for this stock, with most of them expecting it to reach $55.43/share over the next 12 months. If that happens, then CCL would witness a 23.98% rise from its current price. The price of the stock has been moving between $44.37 and $45.3. Not all analysts believe it would hit that target though, as some of them expect it to trade lower, as low as $48 per share. In the same breath, one analyst believes that the stock is set to soar even higher than expected, as the price target was set at $68.
The stock is currently neutral as its Stochastic Oscillator (%D) is at 40.01%, which implies that a stability in price will be experienced for a while. Its shares P/S ratio is below the 2.82 industry average and below the 387.99 by the wider market, as CCL’s P/S ratio currently stands at 1.55. The stock’s estimated price-earnings (P/E) multiple is 9.53 which is also below the 12-month price-earnings (P/E) which stands at 10.51. Carnival Corporation has experienced a rise in its earnings, recording an increase rate of 26.7% in each quarter over the past five years.
The stock has an average rating of 2.4 which means that it has been rated as a Hold by most analysts. The stock is being covered by 21 analysts who gave a consensus recommendation of 2.4 which implies that it is currently in a neutral situation. Reuters looked into analysts covering Carnival Corporation, and 12 of them believe that the stock is a Hold at the moment. 9 of the analysts rated it as a Buy or a Strong Buy while the remaining analysts (0) rated it as a sell at the moment.